The Global Vanguard of Medical Intelligence: How Startups are Scaling Agentic AI in 2026

By 2026, the healthcare sector has reached a definitive shift toward "Agentic AI," where autonomous, goal-directed systems move beyond simple text generation to proactive clinical intervention. This report analyzes how top startups are achieving measurable ROI—often within 14 months—by automating administrative exhaustion, pioneering atomic-resolution drug discovery, and deploying low-cost AI diagnostics in underserved regions. Explore a new seven-dimensional taxonomy for evaluating AI maturity alongside real-world outcomes from innovators like Neko Health, Biofourmis, and Isomorphic Labs.

Medical Television

Feb 24, 2026 - 04:09

0 7

The Global Vanguard of Medical Intelligence: How Startups are Scaling Agentic AI in 2026

The healthcare landscape of 2026 has reached a definitive inflection point, characterized by the transition from experimental generative artificial intelligence to the pervasive integration of "Agentic AI." This shift represents a fundamental transformation in how medical startups develop, deploy, and scale technology. While the previous three years were dominated by the exploration of Large Language Models (LLMs) for text generation and rudimentary chatbots, 2026 is defined by autonomous, goal-directed systems capable of multi-step planning, reflective reasoning, and cross-domain task orchestration.1 These agentic systems function not merely as assistive tools but as collaborative teammates that proactively monitor patient data, reason through complex clinical contexts, and execute high-stakes actions with minimal human intervention.2

This revolution is occurring against a backdrop of acute global pressures, including a projected shortfall of 11 million healthcare workers by 2030 and an urgent economic necessity for health systems to protect margins through automation.5 Startups in 2026 have moved beyond "shiny object" chasing toward stabilizing high-value workflows that deliver tangible return on investment (ROI), often realized within 14 months of deployment.7 From the emergence of "Biology Super Intelligence" in drug discovery to the deployment of low-cost AI microscopes in sub-Saharan Africa, the 2026 startup ecosystem reflects a nuanced, global, and multi-modal approach to the world’s most pressing medical challenges.10

The Architectural Foundation of 2026 Healthcare AI

The technical sophistication of startups in 2026 is anchored in a move toward multi-agent designs and integrated data ecosystems. The "siloed data" era has largely collapsed, replaced by standardized interoperability that supplies sophisticated AI models with the scope of insights required for longitudinal patient mapping.13 This infrastructure supports the "Agentic AI" paradigm, which is distinguished from traditional generative AI by its capacity for autonomous action in the physical and digital worlds, such as independently ordering diagnostic tests or adjusting medication dosages based on real-time physiological feedback.1

The Seven-Dimensional Taxonomy for Agent Evaluation

Research in 2026 has established a standardized framework for evaluating the efficacy of these autonomous systems. This taxonomy allows clinicians and administrators to appraise the "maturity" of agents across seven critical dimensions.

Dimension	Technical Focus	Core Functionality
Cognitive Capabilities	Reasoning & Planning	Dynamic task decomposition and multi-step decision-making using Chain-of-Thought (CoT) prompting.3
Knowledge Management	External Integration	Leveraging RAG (Retrieval-Augmented Generation) to integrate peer-reviewed literature and EHR data.14
Interaction Patterns	Multi-modal Interface	Moving beyond text to voice-first, event-triggered activation and human-in-the-loop (HITL) workflows.3
Adaptation & Learning	Self-Correction	Drift detection and Reinforcement Learning from Human Feedback (RLHF) to refine behavior over time.2
Safety & Ethics	Compliance & Bias	Implementation of safety guardrails, privacy-preserving mechanisms, and bias-aware training.3
Framework Typology	Orchestration	Use of decentralized computational networks where primary agents coordinate sub-specialized support agents.1
Core Tasks	Clinical Utility	Deployment in triage, differential diagnosis, drug discovery, and surgical planning.3

The analysis of 49 major studies in early 2026 indicates that while startups excel in information-centric tasks like medical question answering, there remains a substantial implementation gap in action-oriented areas such as direct treatment prescription, where roughly 59% of systems still require higher levels of compliance and adaptation maturity.14 To address this, organizations are adopting "Unified Agent Lifecycle Management" (UALM) blueprints to govern "agent sprawl," ensuring that every autonomous entity has a clear identity, persona registry, and a "kill-switch" trigger for safety enforcement.2

Eradicating Administrative Exhaustion: The First Success Story

Ambient speech technology has become healthcare's first undisputed AI success story in 2026.7 Startups such as Abridge, DeepScribe, Suki, and Prosper AI have fundamentally redefined the patient-provider encounter by automating documentation and reducing the cognitive load on clinicians.17 These platforms use multi-modal models to listen to clinical conversations, parse medical shorthand, and generate structured notes that integrate directly into the Electronic Health Record (EHR).7

Revenue Cycle and Operational Intelligence

Beyond the exam room, AI agents are transforming the "back office" of medicine. Revenue Cycle Management (RCM) has emerged as a major focus for startups aiming to solve the $350 billion administrative burden in US healthcare.20

Fathom and Nym: These companies deploy deep-learning and NLP engines that code encounters autonomously at an enterprise scale. Fathom has processed over 63 million encounters across 3,000 sites, reducing cycle times from days to hours and ensuring compliant claims are pushed straight to billing.17
Waystar: This firm introduced an AI system specifically designed to automate insurance claim appeals. By reviewing patient records and denial rationales, the AI produces evidence-supported appeal letters, aiming to recover revenue from the 450 million claims denied annually.21
HeyRevia: Founded by former Google engineers, this startup automates complex phone-based workflows, including insurance verification and prior authorizations. Their voice AI handles hundreds of calls simultaneously, achieving 500% of the output of traditional teams.19
Prosper AI: This startup provides HIPAA-compliant voice agents for patient access, ensuring that routine calls for scheduling and billing are resolved instantly without human intervention.17

These operational efficiencies are no longer seen as optional. Financial pressures have created a "perfect storm" where health systems must adopt AI to remain economically viable.6 The shift toward "intelligent revenue cycles" is fueled by the tangible ROI of faster reimbursement and the reduction of manual errors in billing.7

Diagnostic Frontiers: Multi-modal Vision and Pathology

In 2026, diagnostic AI has matured from a triage tool into an essential part of the clinical decision-making pathway. Startups are leveraging computer vision and multi-modal models to identify conditions that are often missed by the human eye or require hours of specialist review.5

Radiology and Cardiovascular Screening

Imaging startups have transitioned from simple "flagging" to comprehensive analysis. Aidoc and Viz.ai utilize real-time algorithms to detect life-threatening conditions such as brain bleeds, pulmonary embolisms, and strokes, immediately alerting care teams and coordinating specialist interventions.17

Startup	Specialization	Clinical Impact / Metric
Cleerly	Coronary Plaque	Changed patient management in 57%+ of cases by quantifying plaque from CT scans.17
Qure.ai	Global Radiology	Processed 45M+ scans; achieved a 40% reduction in turnaround time for chest X-rays.23
Infervision	Lung Oncology	99.1% sensitivity in nodule detection, outperforming specialist radiologists in blinded studies.24
Eko Health	Cardiology	AI-enhanced stethoscopes detect heart failure and valve disease 2-3x more effectively than standard tools.21
RapidAI	Neurovascular	Automates neurovascular imaging to accelerate "time-to-treatment" for stroke patients.17

A notable breakthrough in 2026 is the use of "physics-informed machine learning," a method developed by University of Hawaii researchers that allows AI to adhere to the laws of physics when processing sparse medical datasets. This ensuring that diagnostic outputs remain physically plausible and reduces the "black box" risks associated with traditional deep learning.25

Digital Pathology and Molecular Inference

The field of pathology is being "redefined" by startups that use AI to infer molecular data directly from digitized tissue samples.17 Imagene and PathAI are leaders in this space, using computer vision to read routinely digitized biopsies like molecular tests.17 Imagene’s "LungOI" test, for example, provides rapid biomarker prediction for non-small cell lung cancer (NSCLC), delivering reports the next day that would traditionally take weeks of expensive genomic sequencing.17 Similarly, Owkin has validated "BRCAura," an AI-driven screening tool that detects gBRCA mutations directly from pathology slides, democratizing access to precision oncology.27

"Hospital at Home": The Decentralization of Acute Care

The integration of AI into remote patient monitoring (RPM) has enabled a new era of "Hospital at Home" models, where acute care is delivered in the patient's residence. Biofourmis and CopilotIQ, having merged in late 2024, now offer an AI-driven platform that manages the entire care continuum from pre-surgical optimization to chronic condition management.28

Case Study: AdventHealth and Biofourmis

In 2026, AdventHealth in Central Florida expanded its whole-person care strategy by integrating Biofourmis’ enterprise platform with its Epic EHR.28 This collaboration allows inpatient clinicians to manage acute care for patients at home using FDA-cleared AI algorithms and continuous biomarker data.28

Outcome Area	Statistical Impact
Hospital Readmissions	70% reduction in 30-day readmissions.30
Deterioration Detection	Identification of clinical decline 21 hours sooner than traditional methods.30
Cost of Care	Reduction in total care costs by up to 38%.30
Patient Safety	Integrated fall detection and arrhythmia alerts integrated into daily monitoring.28

This decentralization is further supported by the deployment of "Agentic AI" that proactively monitors wearable data streams. For instance, in 2026, these systems can autonomously adjust personalized treatment plans or synchronize with EHRs to identify potential health crises before they escalate.4 For the elderly, smart floor sensors and automated pill dispensers have reduced hospitalizations from falls by 35% and medication errors by 40%, respectively.31

The Drug Discovery Revolution: AlphaFold 3 and Protein Engineering

Perhaps the most disruptive use of AI in 2026 is found in drug discovery, where the timeline for bringing a drug to market is being condensed from a decade to potentially just two years.32 Isomorphic Labs (Alphabet) and Xaira Therapeutics are at the forefront of this transformation, treating biology as an "information processing problem".32

Atomic Resolution and Protein Design

Isomorphic Labs utilizes "AlphaFold 3" to predict interactions between proteins, DNA, RNA, and small molecules at atomic resolution.32 By early 2026, the company is preparing for its first human trials, marking a transition from AI theory to clinical reality.32 The magnitude of this shift is reflected in their partnerships with Eli Lilly and Novartis, worth a combined $3 billion—the largest in the history of AI drug discovery.32

Xaira Therapeutics, emerging with a $1 billion Series A round, utilizes "RFdiffusion" and "RFantibody" models originally developed in David Baker’s lab at the University of Washington.32 Unlike traditional drug discovery, which relies on screening existing libraries or animal immunization, Xaira engineers specific therapeutic proteins to bind to validated "undruggable" targets.32 Their models are so efficient they may require testing only one molecule per design challenge, compared to the tens of thousands required in traditional methods.32

Federated Learning and Biological Super Intelligence

Owkin (France) has developed "Owkin Zero," a biological LLM fine-tuned specifically on multimodal patient data.12 Owkin’s unique advantage is its pan-European federated learning network, which allows AI models to be trained across 45 academic medical centers without raw patient data ever leaving the hospitals' secure servers.33 This ensures "data sovereignty" while providing the model with the diverse datasets needed for superior generalizability.27 In early 2026, Owkin partnered with NVIDIA to accelerate its "Biology Super Intelligence" (BASI) initiative, seeking to map the tumor microenvironment using the world’s largest spatial multi-omics dataset.33

Regional Insights: India, China, and Africa’s AI "Leapfrog"

While the US still leads in private AI investment—reaching $109.1 billion in 2024—emerging markets are closing the quality gap by deploying AI solutions tailored to their specific resource constraints.34

The Asian Powerhouse: Scale and Speed

In Asia, the rollout of 5G networks in China and Singapore has enabled low-latency telemedicine and real-time surgical monitoring.23 China’s market reached $23.8 billion in 2026, driven by companies like iFlytek, which has deployed medical AI assistants to 35,000 primary care clinics to support rural village doctors.24

Apollo Hospitals (India): Has deployed an AI clinical decision support system across 73 hospitals, reducing diagnostic errors by 34% and decreasing diagnosis time for complex cases from 72 hours to under 12 hours.24
JD Health (China): Serves 180 million active users; AI symptom assessments precede 78% of consultations, and their chronic disease management program has achieved a 34% improvement in medication adherence.24
Smart Nation (Singapore): The "AimSG" platform integrates AI-based imaging across public hospitals, while the SELENA+ system screens 600,000 patients annually for diabetic retinopathy with 95.8% sensitivity.24

Africa’s Data-Driven Renaissance

The 2026 spotlight on "Africa's Top 25 AI in Healthcare Voices" signals a shift toward locally shaped, intelligent health systems.11 African startups are "leapfrogging" traditional infrastructure through high-impact diagnostic tools.

Startup	Country	Innovation	Impact
minoHealth AI Labs	Ghana	Deep learning for chest X-rays	AUC-ROC of 0.97, outperforming human radiologists by 10%.11
Dawa Health	Zimbabwe	Multimodal AI for rural care	Detected pre-cancerous lesions with 96.7% accuracy.11
PapsAI	Uganda	AI digital microscope	Analyzes cervical cancer slides with 99.3% accuracy in 2 minutes.11
Lelapa AI	South Africa	VulaBula API	Enables symptoms to be described in local African languages for AI parsing.11
Famasi Africa	Nigeria	"Remi" AI Agent	Predicts medication stock-outs and manages refills for 20,000+ patients.11

A critical development in 2026 is the deployment of Africa’s first clinical Speech-to-Text AI trained specifically on African accents, which reduced radiology reporting time at University College Hospital, Ibadan, from 48 hours to 20 minutes.11

Ethical Stewardship and the Mitigation of Algorithmic Bias

The transition to autonomous AI in 2026 has brought the risks of "black box" algorithms and systemic bias to the forefront.26 AI models that predict cardiovascular events have been found less accurate in female patients if trained primarily on male datasets.26 Startups are now mandated to implement rigorous bias-mitigation strategies.

Technical Strategies for Fairness

To maintain trust among providers and patients, startups are adopting a multi-faceted approach to ethical AI.16

Diverse Dataset Curation: Deliberately targeting and accounting for underprivileged groups in the training phase to reflect representative demographics.16
Adversarial Debiasing: Using machine learning techniques to adapt the training process, lessening discrepancies in predictions across different subgroups.16
Federated Learning: Ensuring models incorporate insights from diverse local sources without exchanging sensitive patient data, thus preserving privacy while enhancing equity.16
Synthetic Data Generation: Tackling the data anonymization and generalizability problem by creating high-quality synthetic datasets that represent minority populations.16
Explainable AI (XAI): Developing "deterministic algorithms" that provide clear insights into how conclusions are reached, which regulators like the FDA now indicate are the only way to fully vet AI for clinical use.16

By breaking down performance metrics—such as sensitivity and specificity—by subgroup, developers can ensure that optimizing for overall accuracy does not hide disparities in care for marginalized groups.37

Market Dynamics: Consolidation, M&A, and Funding in 2026

The healthcare AI funding landscape in early 2026 has shifted from speculative "hype" to a focus on scale-ups and high-quality assets.38 Investors are prioritizing "unit economics" and the use of venture debt over aggressive equity dilution.39

Major M&A and Funding Deals (February 2026)

Deal Type	Company / Buyer	Value	Strategic Rationale
Acquisition	Sanofi / Dynavax	$2.2B	Strengthening vaccine and immunology focus.40
Acquisition	Eli Lilly / Orna	$2.4B	Engineering immune cells in vivo.40
Acquisition	Danaher / Masimo	$9.9B	Strategic expansion into pulse oximetry and diagnostics.42
Acquisition	OpenAI / Torch	$100M	Acqui-hire to integrate "unified medical memory" into ChatGPT Health.9
Acquisition	Gilead / Arcellx	$7.8B	Expanding oncology and next-gen cell therapy pipeline.42
Funding	Garner	$118M	Series D led by Kleiner Perkins for data analytics.40
Funding	d.light (Africa)	$300M	Record debt financing for pay-as-you-go health/solar models.44

This "Centralize to Modernize" trend is a response to cost pressures, where organizations prioritize assets that strengthen operational efficiency and data connectivity.43 The average disclosed deal value in the healthtech sector has risen more than four-fold since 2023, signaling a clear shift toward capital-intensive segments like infrastructure, MedTech, and hospital networks.38

The Future of Participatory Medicine: Neko Health and Preventive Care

The year 2026 sees the ultimate goal of digital health within reach: the transition from reactive treatment to proactive prevention. Neko Health, co-founded by Daniel Ek, exemplifies this vision. Their 3D full-body scanners, which provide millions of data points in 60 minutes, have already begun to "turn the notion of healthcare on its head".45

Clinical Results of Preventive Screening

Data released by Neko Health in 2025 and early 2026 demonstrates the measurable impact of proactive scanning on otherwise asymptomatic populations.48

Life-Saving Interventions: 1.2% of scans (52 members in one cohort) resulted in potentially life-saving diagnoses, including skin cancers and severe cardiovascular disease.48
Significant Conditions: 4.0% of scans identified significant health conditions, such as hypertension, valve disease, or severe metabolic disorders.48
Reversible Findings: 1.2% of members were diagnosed with reversible conditions, such as pre-diabetic blood sugar levels or early-stage hypertension, which could be managed before becoming chronic.48
Behavioral Shift: Among repeat scan members, 77% of those previously diagnosed with a significant condition had successfully brought it under control or improved their health metrics within one year.48

Neko’s expansion to New York City in Spring 2026, with over 300,000 people on the global waitlist, highlights the massive consumer demand for personalized health insights outside of traditional hospital settings.45

Conclusion: The Integrated Intelligence of 2026

The research across global startups in 2026 reveals an industry that has moved past the "experimentation" phase into a "stabilization" phase where AI is fundamental to the backbone of healthcare operations.7 Agentic AI represents a fundamental paradigm shift toward collaborative intelligence, where autonomous systems execute multi-step goals—from identifying molecular targets to optimizing surgical workflows and managing hospital resources.1

The success of these startups is increasingly measured not by the complexity of their models, but by their ability to prove ROI through Smarter care—catching missed conditions, reducing clinician burnout, and expanding access to underserved regions.35 While challenges in ethical governance, data privacy, and the "digital divide" remain, the evidence from 2026 suggests that the integration of technology and human expertise is finally delivering a healthcare system that is more efficient, predictive, and, ultimately, patient-centered.5 The future of medicine in 2026 is no longer a promise; it is an active, rapidly scaling, and data-driven reality.

Works cited

Agentic AI, Medical Morality, and the Transformation of the Patient-Physician Relationship - arXiv, accessed February 24, 2026, https://arxiv.org/pdf/2602.16553
Agentic AI Governance and Lifecycle Management in Healthcare - arXiv, accessed February 24, 2026, https://arxiv.org/html/2601.15630v1
Agentic AI in Healthcare & Medicine: A Seven-Dimensional Taxonomy for Empirical Evaluation of LLM-based Agents - arXiv, accessed February 24, 2026, https://arxiv.org/html/2602.04813v1
Exploring Agentic AI in Healthcare: A Study on Its Working Mechanism - PMC, accessed February 24, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC12890637/
The Future of Medicine: 6 Ways AI is Transforming Healthcare in 2025 - Launch Consulting, accessed February 24, 2026, https://www.launchconsulting.com/posts/the-future-of-medicine-6-ways-ai-is-transforming-healthcare-in-2025
Top Healthcare AI Trends in 2026 | Blank Rome LLP, accessed February 24, 2026, https://www.blankrome.com/news/top-healthcare-ai-trends-2026
Healthcare AI Update 2025: The Practical AI Use Cases Healthcare Is Scaling Today, accessed February 24, 2026, https://engage.klasresearch.com/blog/healthcare-ai-update-2025-the-practical-ai-use-cases-healthcare-is-scaling-today/9515/
2026 healthcare AI trends: Insights from experts | Wolters Kluwer, accessed February 24, 2026, https://www.wolterskluwer.com/en/expert-insights/2026-healthcare-ai-trends-insights-from-experts
AI In Healthcare Market Size & Share | Industry Report, 2033 - Grand View Research, accessed February 24, 2026, https://www.grandviewresearch.com/industry-analysis/artificial-intelligence-ai-healthcare-market
Global Health Trends for 2026: Financing, AI, and Geopolitics, accessed February 24, 2026, https://bayareaglobalhealth.org/alliance-news/global-health-trends-for-2026-financing-ai-and-geopolitics/
Africa's Top 25 AI in Healthcare Voices 2026 Signals a New Era for Data-Driven Health Systems - The Next Africa, accessed February 24, 2026, https://thenextafrica.com/africas-top-25-ai-in-healthcare-voices-2026-signals-a-new-era-for-data-driven-health-systems/
Global AI Impact Summit 2026, India: Owkin strengthens its strategic partnerships with India to advance biological artificial super intelligence, accessed February 24, 2026, https://www.owkin.com/newsfeed/global-ai-impact-summit-2026-india-owkin-strengthens-its-strategic-partnerships-with-india-to-advance-biological-artificial-super-intelligence
AI in Healthcare: 3 Predictions for 2026, accessed February 24, 2026, https://www.snowflake.com/en/blog/ai-in-healthcare/
(PDF) Agentic AI in Healthcare and Medicine: A Seven-Dimensional Taxonomy for Empirical Evaluation of LLM-Based Agents - ResearchGate, accessed February 24, 2026, https://www.researchgate.net/publication/399473287_Agentic_AI_in_Healthcare_Medicine_A_Seven-Dimensional_Taxonomy_for_Empirical_Evaluation_of_LLM-based_Agents
[2602.04813] Agentic AI in Healthcare & Medicine: A Seven-Dimensional Taxonomy for Empirical Evaluation of LLM-based Agents - arXiv, accessed February 24, 2026, https://arxiv.org/abs/2602.04813
Bias in Medical AI: Algorithmic Fairness and Ethics Challenges, accessed February 24, 2026, https://www.jyi.org/2026-january-1/2026/1/8/bias-in-medical-ai-algorithmic-fairness-and-ethics-challenges
Top AI Healthcare Companies in 2026: Leaders to Watch - Prosper AI, accessed February 24, 2026, https://www.getprosper.ai/blog/the-top-20-ai-healthcare-companies-of-2025-to-watch
The Medical Futurist's 100 Digital Health And AI Companies Of 2026, accessed February 24, 2026, https://medicalfuturist.com/the-medical-futurists-100-digital-health-and-ai-companies-of-2026
The Top 12 Healthcare AI Companies in 2026 (And Why) - OpenLoop Health, accessed February 24, 2026, https://openloophealth.com/blog/top-12-healthcare-ai-companies-in-the-us-in-2026
AI in Healthcare 2026: Risks, Opportunities, and What Clinicians Must Know - CM&F Group, accessed February 24, 2026, https://www.cmfgroup.com/blog/healthcare-professionals/what-clinicians-need-to-know-about-ai-risks-opportunities-in-2026/
AI Healthcare Breakthroughs 2025: 10 Innovations Transforming Care, accessed February 24, 2026, https://www.alation.com/blog/ai-healthcare-breakthroughs-2025-innovations/
Healthcare AI Companies: Real-World Solutions & Emerging Leaders in 2025 - qBotica, accessed February 24, 2026, https://qbotica.com/healthcare-ai-companies-real-world-solutions-emerging-leaders-in-2025/
Top Digital Health Trends in Asia for 2026 and Beyond, accessed February 24, 2026, https://smarthealthasia.com/blog/top-digital-health-trends-in-asia-for-2026/
Latest AI in Healthcare Examples in 2026 in India, Australia, UK ..., accessed February 24, 2026, https://business20channel.tv/latest-ai-in-healthcare-examples-in-2026-in-india-australia-uk-europe-dubai-uae-saudi-arabia-turkey-brazil-singapore-and-china-20-12-2025
Latest AI News and AI Breakthroughs that Matter Most: 2026 & 2025 | News - Crescendo.ai, accessed February 24, 2026, https://www.crescendo.ai/news/latest-ai-news-and-updates
Overcoming AI Bias: Understanding, Identifying and Mitigating Algorithmic Bias in Healthcare - Accuray, accessed February 24, 2026, https://www.accuray.com/blog/overcoming-ai-bias-understanding-identifying-and-mitigating-algorithmic-bias-in-healthcare/
News Center - Owkin, accessed February 24, 2026, https://www.owkin.com/news
Biofourmis Selected by AdventHealth to Support “Whole-Person Care” With New Acute Care-at Home Program, accessed February 24, 2026, https://biofourmis.com/news-insights/biofourmis-selected-by-adventhealth-to-support-whole-person-care-with-new-acute-care-at-home-program
CopilotIQ, Biofourmis merge for AI Home Care - IoT M2M Council, accessed February 24, 2026, https://iotm2mcouncil.org/iot-library/news/connected-health-news/copilotiq-biofourmis-merge-for-ai-home-care/
Biofourmis | Revolutionize the delivery of care, accessed February 24, 2026, https://biofourmis.com/
How AI-Powered Home Health Services Improve Senior Care in 2026, accessed February 24, 2026, https://allseniors.org/articles/how-ai-powered-home-health-services-improve-senior-care-in-2026/
Top Healthtech Trends and Startups to Watch in 2026 - Monterail, accessed February 24, 2026, https://www.monterail.com/blog/top-healthtech-trends-and-startups
Companies Applying AI to De-Risk Clinical Trials: 2026 Watchlist, accessed February 24, 2026, https://www.biopharmatrend.com/business-intelligence/companies-applying-ai-to-de-risk-clinical-trials-2026-watchlist/
The 2025 AI Index Report | Stanford HAI, accessed February 24, 2026, https://hai.stanford.edu/ai-index/2025-ai-index-report
AI and Machine Learning in Healthcare: Impact & Implementation, accessed February 24, 2026, https://smarthealthasia.com/blog/artificial-intelligence-and-machine-learning-in-healthcare-asia/
Bias recognition and mitigation strategies in artificial intelligence healthcare applications, accessed February 24, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC11897215/
Clinical AI Bias Testing: How to Assess and Mitigate Algorithmic Risks in Healthcare, accessed February 24, 2026, https://censinet.com/perspectives/clinical-ai-bias-testing-how-to-assess-and-mitigate-algorithmic-risks-in-healthcare
Africa HealthTech Growth & Exit Outlook for 2026 - ICON Corporate Finance, accessed February 24, 2026, https://www.iconcorpfin.com/wp-content/uploads/2025/11/Africa_HealthTech_Report.pdf
Latest African Tech Startup Funding Rounds: 2026 Trends - TechCity, accessed February 24, 2026, https://www.techcityng.com/latest-african-tech-startup-funding-rounds-2026-trends/
Healthcare Private Placement and M&A Transactions Review Week Ending February 15, 2026 | Silverwood Partners, accessed February 24, 2026, https://silverwoodpartners.com/healthcare-private-placement-and-ma-transactions-review-week-ending-february-15-2026/
Biotech Startup M&A Is Reliably Delivering Some Big Exits - Crunchbase News, accessed February 24, 2026, https://news.crunchbase.com/health-wellness-biotech/startup-ma-ipo-delivering-exits/
Healthcare News, Deals, and Investments Update Feb 23rd, 2026 - Lawrence, Evans & Co. LLC, accessed February 24, 2026, http://www.lawrenceevans.com/2026/02/23/healthcare-news-deals-and-investments-update-feb-23rd-2026/
Healthcare M&A in 2026: A Roundup of Deals - Xtalks, accessed February 24, 2026, https://xtalks.com/healthcare-ma-in-2026-a-roundup-of-deals-4615/
Top Startups in Africa 2026 and Their Funding Landscape, accessed February 24, 2026, https://arabfounders.net/en/top-startups-africa-2026-2/
Neko Health Celebrates One Year in the UK with Covent Garden Opening, Expanding Capacity for Preventive Care, accessed February 24, 2026, https://www.nekohealth.com/se/en/neko-health-celebrates-one-year-in-the-uk
Neko Health Opens Its Largest Ever Health Centre in London, accessed February 24, 2026, https://www.nekohealth.com/se/en/neko-health-spitalfields
Neko Health to Launch First U.S. Location in New York City in Spring 2026, accessed February 24, 2026, https://www.nekohealth.com/se/en/neko-health-to-launch-first-us-location-in-new-york-city
Neko Data Story: Year Two - Neko Health, accessed February 24, 2026, https://www.nekohealth.com/gb/en/neko-data-story-year-two
Neko Data Story: Repeat Scans Show Health Improvements, accessed February 24, 2026, https://www.nekohealth.com/se/en/repeat-scans-show-health-improvements
The Future of AI in Healthcare – 2026 | SS&C Blue Prism, accessed February 24, 2026, https://www.blueprism.com/resources/blog/the-future-of-ai-in-healthcare/

Click Here To See More